Dr. Richard Drayer, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 149 Frankfort St, Versailles, KY 40383 Phone: 859-873-7805 Fax: 859-873-9653 |
Kentucky Eye Institute Optometrist Medicare: Not Enrolled in Medicare Practice Location: 149 Frankfort St, Versailles, KY 40383 Phone: 859-873-7805 Fax: 859-783-9653 |
Dr. Regina Callihan, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 105 Crossfield Dr, Versailles, KY 40383 Phone: 859-879-3665 |
Family Eyecare Associates Psc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 105 Crossfield Dr, Versailles, KY 40383 Phone: 859-879-3665 Fax: 859-879-3662 |
Childrens Vision And Learning Center, Psc Optometrist - Vision Therapy Medicare: Medicare Enrolled Practice Location: 105 Crossfield Dr, Versailles, KY 40383 Phone: 859-879-3665 Fax: 859-879-3662 |
Brent Kramer, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 149 Frankfort St, Versailles, KY 40383 Phone: 859-873-7805 |
Dr. Richard Graebe Ii Optometrist Medicare: Accepting Medicare Assignments Practice Location: 105 Crossfield Dr, Versailles, KY 40383 Phone: 859-879-3665 Fax: 859-879-3662 |
Family First Vision Care Kentucky, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 105 Crossfield Dr, Versailles, KY 40383 Phone: 859-879-3665 |
Dr. Steven Trevor Smith, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 105 Crossfield Dr, Versailles, KY 40383 Phone: 859-879-3665 |
News Archive
As in adults, migraine surgery is effective for selected adolescent patients with severe migraine headaches that don't respond to standard treatments, reports a study in the June issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Healthcare professionals who specialize in wound, ostomy and/or continence care will have the opportunity to participate in a groundbreaking conference that combines the expertise of two premier wound, ostomy and continence associations, The Wound, Ostomy and Continence Nurses Society and The World Council of Enterostomal Therapists.
Intellipharmaceutics International Inc., today announced that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for approval to market a generic of the 30 mg strength of Focalin XR® (dexmethylphenidate hydrochloride). The application for the 30 mg strength is filed as an amendment to the ANDA that Intellipharmaceutics had previously filed for the 5, 10, 15 and 20 mg strengths of the drug.
Dr. Roger Zemek, Director of Emergency Research at the CHEO Research Institute and ED physician, and assistant professor in the Faculty of Medicine at the University of Ottawa, has overseen the creation and implementation of a Medical Directive that now empowers nurses to administer an oral steroid treatment, which has reduced wait time and improved patient care. This research is published today in Pediatrics.
› Verified 7 days ago